Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...
Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...
Hosted on MSN
Silicon chips on the brain: Researchers develop new generation of brain-computer interface
A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological conditions such as epilepsy, spinal cord injury, ALS, stroke, and ...
Science Corp., a developer of brain-computer interfaces and other medical equipment, today announced that it has raised $230 million in funding. The capital came from a consortium that included ...
Casey Harrell, a man with the progressive muscle disease amyotrophic lateral sclerosis (ALS), reacts to using a brain-computer interface to 'speak' for the first time. The device interprets brain ...
Everyone – ourselves included – is talking about AI these days, for good reason. AI models now draft legal contracts, design chips, code software, edit videos, discover drugs, even run autonomous labs ...
California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. Cognixion is one of several ...
Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...
In May 2025, a €4 million grant was awarded to INBRAIN Neuroelectronic, a company developing precision graphene-based brain-computer interfaces, by the Spanish Ministry of Industry and Tourism through ...
China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results